Tnf Pharmaceuticals, Inc.
TNFA
Revenue
-1.89k
▼-365.40k▼-100.52%
3 Months ChangeAssets
26.38M
▲11.89M▲82.03%
3 Months ChangeLiabilities
26.00M
▲21.75M▲511.38%
3 Months ChangeFree Cash Flow
-1.82M
▼-245.77k▼-15.57%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-10-07
Form 8-K
ID: 0001493152-24-040276
2024-10-04
Form 8-K
ID: 0001493152-24-039556
2024-09-23
Form 8-K
ID: 0001493152-24-037819
2024-08-19
Form 10-Q
ID: 0001493152-24-032940
2024-08-14
Form 8-K
ID: 0001493152-24-032169
2024-07-26
Form 8-K
ID: 0001493152-24-029243
2024-07-26
Form 8-K
ID: 0001493152-24-029227
2024-06-24
Form 8-K
ID: 0001493152-24-024960
2024-06-17
Form 8-K
ID: 0001493152-24-024046
2024-05-23
Form 8-K
ID: 0001493152-24-021143